OTC · Biotechnology

Calithera Biosciences, Inc. (CALA) Stock

$0.00 OTC: CALA Healthcare

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023.

Valuation

MetricValue
Price$0.00
Market Cap$487
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-7.94
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-95.00%
ROA-65.52%
ROCE-197.66%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.10
Current Ratio3.86

Annual Financials (USD)

Metric20182019202020212022
Revenue$22.0M$0$0$10.0M$0
Operating Profit$-57.0M$-93.0M$-91.0M$-114.0M$-42.0M
Net Profit$-51.0M$-86.0M$-89.0M$-115.0M$-19.0M
EPS$-28.12$-36.50$-26.20$-31.16$-7.94
Op Margin-257.4%——-1172.1%—

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$143.0M$169.0M$126.0M$65.0M$29.0M
Total Liabilities$16.0M$26.0M$23.0M$56.0M$8.0M
Cash$51.0M$60.0M$107.0M$60.0M$25.0M
Borrowings$0$8.0M$7.0M$3.0M$2.0M

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-65.0M$-79.0M$-84.0M$-66.0M$-44.0M
Investing Cash Flow$53.0M$-11.0M$89.0M$8.0M$0
Financing Cash Flow$1.0M$1.0M$1.0M$0$0
Net Cash Flow$3.0M$9.0M$47.0M$-48.0M$-34.0M
Free Cash Flow$-65.0M$-79.0M$-84.0M$-66.0M$-44.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.62
FCF Yield-8981724.85%
Quick Ratio3.60
Interest Coverage0.00
Return 1Y0.00%
Return 3Y-99.80%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARNIArno Therapeutics, Inc. $0.00 — 0.00 $4935 0.00%
BTTXBetter Therapeutics, Inc. $0.00 — 0.00 $5452 0.00%
BXRXQBaudax Bio, Inc. $0.00 — 0.00 $4359 0.00%
IVBTInnovation1 Biotech Inc. $0.00 — 0.00 $4494 0.00%
KLDOKaleido Biosciences, Inc. $0.00 — 0.00 $426 0.00%

About Calithera Biosciences, Inc.

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

Calithera Biosciences, Inc. (CALA) stock trades at $0.00 with a market capitalization of $487. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Calithera Biosciences, Inc. generates a return on equity (ROE) of -95.00%, return on capital employed of -197.66%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.calithera.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides